Workflow
National Research (NRC) - 2024 Q2 - Quarterly Results
NRCNational Research (NRC)2024-08-06 21:07

Financial Performance - Revenue for Q2 2024 was approximately 35million,adecreaseof3.235 million, a decrease of 3.2% compared to 36 million in Q2 2023[2] - Earnings per diluted share were 0.26,downfrom0.26, down from 0.29 in the same quarter last year, representing a decline of 10.3%[2] - Total operating income for Q2 2024 was 8.865million,downfrom8.865 million, down from 9.365 million in Q2 2023, a decrease of 5.3%[10] Contract Value - Total recurring contract value (TRCV) was approximately 138millionasofJune30,2024[2]Acquisition−ThecompanyacquiredNOBLHealthforanenterprisevalueofapproximately138 million as of June 30, 2024[2] Acquisition - The company acquired NOBL Health for an enterprise value of approximately 6 million, with a potential earnout of up to 1millionbasedonfutureperformance[6]Dividend−Thecompanydeclaredaquarterlycashdividendof1 million based on future performance[6] Dividend - The company declared a quarterly cash dividend of 0.12 per share, payable on October 11, 2024[5] Debt and Liabilities - Net indebtedness was approximately 42millionasofJune30,2024[2]−Totalliabilitiesincreasedto42 million as of June 30, 2024[2] - Total liabilities increased to 78.901 million from 73.482millionasofDecember31,2023[11]StockRepurchase−Thecompanyhasapproximately1.1millionsharesremainingunderitsstockrepurchaseplan[4]CurrentAssets−Currentassetsdecreasedto73.482 million as of December 31, 2023[11] Stock Repurchase - The company has approximately 1.1 million shares remaining under its stock repurchase plan[4] Current Assets - Current assets decreased to 16.95 million from $24.36 million as of December 31, 2023[11]